Expression of AXL in the cell cytoplasm of pre-EGFR-TKI-treated tumor samples was evaluated using immunohistochemistry (IHC) staining and scored as very high (3+), high (2+), low (1+), and no (0) expression of AXL (Supplementary Figure 1). The gene discussed is EGFR; the disease is neoplasm.